Soluble Lectin-like Oxidized Low-Density Lipoprotein Receptor 1 Predicts the Changes of Rheumatoid Factor Titers in Rheumatoid Arthritis.
Soluble Lectin-like Oxidized Low-Density Lipoprotein Receptor 1 Predicts the Changes of Rheumatoid Factor Titers in Rheumatoid Arthritis.
复制标题
可溶性凝集素样氧化低密度脂蛋白受体 1 预测类风湿关节炎中类风湿因子滴度的变化。
DOI:
10.1097/rhu.0000000000001116
复制
发表时间:
2019
期刊:
影响因子:
--
通讯作者:
Matsuda S.
中科院分区:
文献类型:
--
作者:
Okahata A;Ito H;Furu M;Ishikawa M;Fujii T;Hashimoto M;Tanaka M;Morita Y;Azukizawa M;Tomizawa T;Doi K;Nishitani K;Murata K;Yoshitomi H;Mimori T;Matsuda S.
ObjectiveThe aim of this longitudinal study was to examine the clinical significance of soluble lectin-like oxidized low-density lipoprotein receptor 1 (sLOX-1) in patients with rheumatoid arthritis.MethodsWe gathered demographic and clinical data for a large rheumatoid arthritis cohort at 3 time points. Blood samples were collected at each time point; the number of samples was 282 cases in 2012, 431 cases in 2013, and 500 cases in 2014. Plasma sLOX-1 was measured by enzyme-linked immunosorbent assay. Correlations between sLOX-1 and clinical data were analyzed. Predictive factors associated with changes in sLOX-1 and rheumatoid factor (RF) were analyzed by multivariate linear regression.Results